Mode
Text Size
Log in / Sign up
N/A N=190 Treatment

Trident® Tritanium™ Acetabular Shell Revision Study

Arthroplasty, Replacement, Hip

Enrolled (actual)
190
Serious AEs
18.0%
Results posted
Nov 2017
Primary outcome: Primary: Number of Hips Requiring Revision or Pending Revision of the Acetabular Shell (as Defined by Radiographic Parameters) Due to Instability or Lack of Fixation — 4 hips

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Trident® Tritanium™ Acetabular Shell (Device)
Age
Adult, Older Adult · 21+ yrs
Sex
All
Sponsor
Stryker Orthopaedics
Primary completion
Sep 2016

Outcome Measures

OutcomeResultp-value
PRIMARY
Number of Hips Requiring Revision or Pending Revision of the Acetabular Shell (as Defined by Radiographic Parameters) Due to Instability or Lack of Fixation
4
SECONDARY
Change in Harris Hip Score (HHS) From Pre-operative to Post-operative Visits
53.40; 79.46; 86.11; 85.34; 86.56; 83.87 <0.0001 sig
SECONDARY
Change in SF-36 From Pre-operative to Post-operative Visits
33.26; 38.9; 43.04; 43.55; 43.54; 42.76 <0.0001 sig
SECONDARY
Radiographic Outcomes: Radiolucency (RLL) Around the Acetabular Shell is Greater Than 2 mm in All Zones
3; 0; 0; 0; 0; 0
SECONDARY
Radiographic Outcomes: Migration of the Acetabular Shell Greater Than 5 mm in Any Direction
0; 0; 0; 0; 0; 0
SECONDARY
Change in Lower Extremity Activity Scale (LEAS) From Pre-operative to Post-operative
8.32; 9.25; 10.5; 10.37; 10.6; 10.25 0.0011 sig

Summary

The purpose of this study is to evaluate a hip implant system used when a previous hip replacement surgery has failed.

Eligibility Criteria

Inclusion Criteria

  • Males and non-pregnant females, 21-85 years of age at the time of surgery.
  • Patient is a candidate for a revision of a failed acetabular component with a cementless acetabular component.
  • Patient has signed an IRB approved study consent form.
  • Patient is willing and able to comply with postoperative requirements including postoperative weight bearing restrictions and self-evaluations.

Exclusion Criteria

  • Patient is morbidly obese, BMI > 40.
  • Patient has a systemic or metabolic bone disorder leading to progressive bone deterioration.
  • Patient is immunologically compromised or receiving steroids in excess of normal physiological requirements (> 30 days).
  • Patient's bone stock is compromised by disease or infection which cannot provide adequate support and/or fixation to the prosthesis.
  • Patient has an active or suspected latent infection on or about the hip joint.
  • Patient is a prisoner.
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT00535626). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search